why remogliflozin is the ideal choice of sglt2i in indian t2dm patients by dr. gourav bandhu
Published 4 weeks ago • No plays • LengthDownload video MP4
Download video MP3
Similar videos
-
remogliflozin : the most studied sglt2i on indian t2dm patients by dr likhita dasari
-
remogliflozin : the most studied sglt2i on indian t2dm patients by dr jagdish patel
-
remogliflozin: the most studied sglt2i on indian t2dm patients by dr. debarghya dey
-
remogliflozin: the most studied sglt2i on indian t2dm patients by dr. umesh kumar sah
-
10:37
cardiovascular outcomes in new users of sglt-2 inhibitors
-
0:54
ask the expert – how do you choose the right medical treatment for diabetes?
-
8:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond - summary presentation
-
5:14
risk for heart failure modulate the effectiveness of empagliflozin ?
-
49:14
dpp4i & sglt2i: perfect partners
-
8:13
professor mansoor husain - clinical benefit of modern therapy for type 2 diabetes – glp-1 analogues
-
1:06:11
iscp 2021 dapagliflozin et al. the growing therapeutic spectrum of sglt2i
-
8:15
sglt2 inhibitors and heart failure
-
54:53
diabetes debunked: fact vs. fiction on ways to prevent, manage, and reverse the disease
-
1:03:28
6/15/18: diabetes & cvd: have we found the holy grail?
-
3:35
sglt-2 inhibitors, explained: how they work, their benefits and risks
-
6:57
how does dapagliflozin work? understanding sglt2 inhibitors.
-
1:14:27
mercodia webinar: dr. ralph defronzo: glucagon release with sglt2 inhibition
-
25:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond
-
7:38
drugs- sglt 2 i dapagliflozin / empagliflozin- pillar for heart failure